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Abstract
Background: Exercise is recommended as a treatment for premenstrual syndrome (PMS) in clinical 
guidelines, but this is currently based on poor- quality trial evidence.
Aim: To systematically review the evidence for the effectiveness of exercise as a treatment for PMS.
Design & setting: This systematic review searched eight major databases, including MEDLINE, 
EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL), and two trial registries 
from inception until April 2019.
Method: Randomised controlled trials (RCTs) comparing exercise interventions of a minimum of 8- weeks 
duration with non- exercise comparator groups in women with PMS were included. Mean change scores 
for any continuous PMS outcome measure were extracted from eligible trials and standardised mean 
differences (SMDs) were calculated where possible. Random- effects meta- analysis of the effect of 
exercise on global PMS symptoms was the primary outcome. Secondary analyses examined the effects 
of exercise on predetermined clusters of psychological, physical, and behavioural symptoms.
Results: A total of 436 non- duplicate returns were screened, with 15 RCTs eligible for inclusion (n 
= 717). Seven trials contributed data to the primary outcome meta- analysis (n = 265); participants 
randomised to an exercise intervention reported reduced global PMS symptom scores (SMD = -1.08; 
95% confidence interval [CI] = -1.88 to -0.29) versus comparator, but with substantial heterogeneity 
(I2 = 87%). Secondary results for psychological (SMD = -1.67; 95% CI = -2.38 to -0.96), physical (SMD 
= -1.62; 95% CI = -2.41 to -0.83) and behavioural (SMD = -1.94; 95% CI = -2.45 to -1.44) symptom 
groupings displayed similar findings. Most trials (87%) were considered at high risk of bias.
Conclusion: Based on current evidence, exercise may be an effective treatment for PMS, but some 
uncertainty remains.
How this fits in
PMS is a common presentation in primary care settings. Many women are keen to use alternative 
methods to medical intervention to improve symptoms, but the evidence for these methods is weak. 
This systematic review and meta- analysis provides further evidence to support the effectiveness 
of exercise in improving symptoms related to PMS, and will support primary care professionals in 
recommending treatments for their patients.
Introduction
PMS describes a broad collection of psychological, physical, and behavioural symptoms, occurring 
in line with the menstrual cycle.1–3 Up to 75% of women may experience symptoms of PMS during 
Pearce E et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101032
 
 2 of 11
Research
their lifetime.1,4 Women with PMS frequently present to primary care with acute symptoms, as well as 
decreased work productivity and relationship difficulties; PMS can also be associated with conditions 
such as hypertension and depression.5–7
Many therapies are recommended for symptom management; for example, both the National 
Institute for Health and Care Excellence (NICE) and the Royal College of Obstetricians and 
Gynaecologists (RCOG) suggest exercise as a first- line treatment, alongside medications such as 
selective serotonin reuptake inhibitors and the combined oral contraceptive pill.1,8 The latter two 
treatments are often effective, but risk side effects such as fatigue, nausea and preclusion of, or 
potential risks to, pregnancy.9,10 Women may also actively prefer alternative therapies.11
Nevertheless, exercise is known to increase endorphin levels, to help regulate progesterone and 
oestrogen synthesis and to encourage the production of endogenous anti- inflammatory chemicals.12–14 
Exercising also brings other benefits such as improved overall fitness, opportunities to socialise, and 
the potential for reduction in feelings of depression, all of which may help to moderate the symptom 
profile in PMS.2,15,16
A previous systematic review of this topic found low- level evidence to support the recommendation 
of exercise for symptom management in PMS.17 It is this review that provides the supporting basis for 
the RCOG recommendation in its PMS guidelines.
Study aim
This study aimed to provide an updated systematic review and meta- analysis of the evidence 
examining the effectiveness of exercise as a treatment for PMS. It also undertook to examine 
the global effect of exercise on PMS symptoms, and the specific effects on each of three 
symptom domains: psychological, physical, and behavioural. These domains are those specified 
in the diagnostic questionnaire recommended for use in the UK, the Daily Record of Severity of 
Problems.18
Method
Data sources and searches
Cochrane Collaboration guidance on systematic reviews of interventions and PRISMA reporting 
guidelines were followed throughout.19,20 The following databases were searched electronically 
for eligible trials: MEDLINE, EMBASE, PSYCInfo, CINAHL, AMED, SPORTDiscus, CENTRAL, and 
clinicaltrials. gov (MEDLINE strategy available at Supplementary figure S1). The World Health 
Organization International Clinical Trials Registry Platform was searched for trials in progress. The 
Directory of Open Access Journals was searched; grey literature was sought from OpenGrey; and the 
authors undertook forward and backward citation searching of included trials.
MeSH and free- text terms relating to the condition of interest (premenstrual syndrome, PMS, 
premenstrual dysphoric disorder, PMDD, and premenstrual tension) were combined with intervention 
terms (sport, exercise, physical activity). Scottish Intercollegiate Guideline Network study design 
limits were applied where possible.21 No restrictions were placed by date, language, or country of 
origin. Searches were undertaken from individual database inception up to April 2018 and refreshed 
in April 2019; one new article was found at this point, however, the data were already included in the 
meta- analysis. The authors were contacted where further information was required. Two researchers 
independently screened all titles and abstracts before reviewing all full- text articles. Any discrepancies 
were discussed with a third researcher.
Study selection
Inclusion criteria used were: (a) populations of women reporting regular menstrual cycles (21–35 
days) and symptoms of PMS; (b) trials delivering any exercise intervention for a minimum of 8 weeks, 
including co- interventions such as nutritional supplements, if delivered to both the exercise and non- 
exercise groups; (c) a non- exercise comparator; (d) any outcome measure quantifying PMS symptoms 
on a continuous scale; and (e) RCTs. Studies comparing two types of exercise without a non- exercise 
comparator were excluded.
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Data extraction and quality 
assessment
Data were independently extracted by two 
reviewers using an a priori designed and piloted 
data extraction form. Data from referenced study 
protocols and author correspondence (where 
applicable and available) were also used to 
provide additional information to undertake the 
quality assessment.
Study quality was independently assessed 
by three reviewers using quality criteria from 
the Cochrane Risk of Bias Tool and adapted for 
inability to blind to group allocation in exercise 
trials. Criteria concerning selection, performance, 
detection, attrition, and reporting biases were 
included and were given equal weighting in the 
final assessment of overall trial quality. Additional 
items relating to recall and observer bias, the 
Hawthorne effect, and contamination bias were 
also assessed as a group to form the final part of 
the study quality score.
The quality of the evidence included was 
assessed by two reviewers using the GRADE 
(Grading of Recommendations Assessment, 
Development and Evaluation) methodology for 
the primary outcome, and all three secondary 
outcomes; the checklist by Meader et al was used 
to guide this assessment.22
Data synthesis and analysis
SMD and the associated 95% CIs were calculated 
using standard methods provided by the 
Cochrane Handbook for Systematic Reviews, 
and guided by a previous systematic review 
on a related topic.16,23 Where studies reported 
>1 intervention arm testing similar exercise 
interventions with differing intensities but only 
one control group, intervention scores were 
combined to produce one group as per Cochrane 
Collaboration guidance.24
Random- effects meta- analysis was used as 
heterogeneity within the results was expected.
Between- studies heterogeneity was examined 
using the I2 statistic, with cut- off points of 25%, 
50%, and 75% considered for low, medium, and 
high heterogeneity, respectively.25 Publication 
bias was assessed narratively by the review team; 
funnel plots were not constructed as <10 trials 
contributed data to either the primary or secondary outcome meta- analyses.
All statistical analyses were performed using RevMan 5.3 and IBM SPSS Statistics (version 24).
Results
Trial selection
Figure 1 PRISMA flow diagram of included and 
excluded studies. PMS = premenstural syndrome. RCT 
= randomised controlled trial.
Pearce E et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101032
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Following removal of duplicates, 435 titles and abstracts were screened. Of these, 58 full texts were 
reviewed and 20 reports of 15 individual trials were found to be eligible for inclusion. A further 
published report of the same trial was found on the PubMed search carried out in April 2019, giving 
21 reports of 15 trials in total (Figure 1 and Supplementary Table S1).26
Trial characteristics
A total of 14 published trials27–40 and one unpublished PhD thesis41 were included in this review. 
Twelve trials were conducted in Iran27,29–35,37–40 (publications for six of these were only available in 
Persian language), one in Egypt,28 and one in South Korea;36 the PhD study was conducted in the US.41 
Sample sizes across the trials ranged from 20–90.
Mean age of participants ranged from 17–34 years across 13 of the trials. Two trials did not publish 
sufficient data regarding age for this to be extracted.37,38 Three trials recruited women from outpatient 
gynaecology clinics with a clinical diagnosis of PMS,28,37,40 and 11 recruited women with symptoms 
reaching their predefined trial inclusion threshold from community- based locations: six recruited from 
universities,30,31,33,35,36,39 one from a school,34 two from the local community,29,41 and two from sports 
clubs.27,32 One study did not report the location for recruitment (Table 1).38
Intervention characteristics
A range of exercise interventions were assessed, including various types of aerobic exercise 
programmes,28,30–32,34,35,37–39,41 yoga regimens,36,40 Pilates regimens,29 water aerobics programmes,33 
and stretching and resistance exercise programmes.27 When assessing if the exercise was performed 
in front of a group and/or a researcher, and therefore potentially subject to the Hawthorne bias, 
eight trials were clearly described as supervised group exercise,27,31–33,35,36,39,40 one as a home- based 
exercise programme to be completed alone,30 and the remaining six trials28,29,34,37,38,41 did not describe 
the setting or supervision level in sufficient detail to allow classification. Eleven trials administered 
the intervention three times per week for the duration of the study period.27–32,35,37,38,40,41 No trial 
delivered the intervention only during the luteal phase. Five trials examined the effects of >1 intensity 
of exercise intervention against a non- exercise comparator.27,32,38,39,41 Intervention duration ranged 
from 8–12 weeks, and exercise session length from 30 minutes-1 hour. Two trials provided nutritional 
supplements to all participants, regardless of group allocation.28,34
Risk of bias in included studies and publication bias
Overall, quality of the included trials was low; two31,39 were considered unclear (moderate) risk of bias, and 
the remainder were considered high risk (Figure 2). Identified issues that introduced risk of bias included 
lack of robust procedures for randomisation, minimal information regarding blinding of participants or 
assessors, and lack of pre- specified outcomes. Overall assessment of the evidence concluded that there 
may be a moderate indication of publication bias owing to a lack of negatively reporting trials.
Study results
All 15 of the included trials reported that exercise significantly decreased symptoms of PMS. Fourteen 
of the 15 trials reported their data in a format that could be used in meta- analysis of either primary 
or secondary outcome; Ilka et al did not report any standard deviations associated with mean scores 
or provide adequate data to calculate them, and the author could not be contacted.29 The trial 
conducted by Pazoki et al contained four groups, analysed in this review as two pairs: a comparison 
of exercise intervention versus control, and a second comparison of exercise intervention plus fennel 
extract versus fennel extract alone.34
Primary outcome
Seven of the 15 eligible trials reported global PMS outcome scores (n = 265).28,32,34–37,41 Meta- analysis 
of the seven trials reporting on the primary outcome showed a statistically significant reduction in the 
SMD for participants randomised to exercise interventions compared with comparators (SMD = -1.08; 
95% CI = -1.88 to -0.29). Significant heterogeneity existed between trials (I2 = 87%) (Figure 3).
secondary outcomes
Eight of the 15 trials reported data exploring the effect of exercise on psychological symptoms (n 
= 427 participants).27,28,30,31,35,38–40 The meta- analysis showed a statistically significant reduction 
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Table 1 Characteristics of included studies.
Study n Participants Interventions Comparators Outcomes Results
Abedy et al, 
2014
30 Sports club 
attendees, Iran 
(20–30 years)
Two intervention groups: stretching 
exercise, resistance exercise; 8- weeks 
duration, three sessions per week, 60 
minutes per session
Usual care Daily Record of 
Severity of Problems 
(not clearly stated 
within text)
Statistically significant 
reduction in psychological 
and behavioural symptoms 
at 8 weeks regardless of 
intervention type




Two intervention groups: moderate 
intensity aerobic stair stepping, low 
intensity aerobic stair stepping; 
12- weeks duration, three sessions per 
weeks, 45 minutes per session
Usual care Daily ratings form Statistically significant 
reduction in overall symptoms 
at 12 weeks regardless of 
intervention intensity
El- Lithy et al, 
2015
30 Outpatient clinic 
attendees, Egypt
(16–20 years)
Aerobic exercise with 50 mg vitamin B6 
and 1200 mg calcium daily; 12- weeks 
duration, three sessions per week, 60 
minutes per session
50 mg vitamin B6 







reduction in overall, 
psychological, and behavioural 
symptoms at 12 weeks
Ilka et al, 2015 50 Local residents, Iran
(20–35 years)
Pilates; 8- weeks duration, three sessions 
per week, 60 minutes per session, 
increasing in intensity










70 University Students, 
Iran (20–40 years)
Home- based aerobic exercise; 8- weeks 
duration, three sessions per week, 20 
minutes per session





reduction in psychological and 
physical symptoms at 8 weeks
Kamalifard et 
al, 2017
62 Outpatient clinic 
attendees, Iran
(20–45 years)
Yoga; 10- weeks duration, three sessions 
per week, 60 minutes per session




reduction in psychological, 
physical, and behavioural 
symptoms at 10 weeks
Mosallanejad 
et al, 2007
40 University students, 
Iran (18–25 years)
Aerobic; 8- weeks duration, three 
sessions per week, 15–45 minutes per 
session (increasing over the 8 weeks)
Not clearly reported, 
assumed usual care
Daily Record of 
Severity of Problems 
(not clearly stated 
within text)
Statistically significant 
reduction in psychological and 
physical symptoms at 8 weeks
Naeini, 2008 57 Sports club 
attendees, Iran 
(18–40 years)
Two intervention groups: 'aerobic', 
'physical'; 12- weeks duration, three 
sessions per week, 20–30 minutes per 
session
Usual care Not clearly described Statistically significant 
reduction in overall symptoms 
at 12 weeks regardless of 
intervention type








Group water aerobics; 8- weeks duration, 
alternate day sessions, 80 minutes per 
session
Not clearly reported Short premenstrual 
assessment form
Statistically significant 
reduction in symptoms at 8 
weeks
Pazoki et al, 
2016
48 High school 
students, Iran (16–18 
years)
Aerobic exercise; 8- weeks duration, 60 
minutes per session. Sessions per week 
not reported
Usual care (two other 
groups received 
fennel extract, and 
fennel extract with 
exercise)
Daily Record of 
Severity of Problems
Statistically significant 
reduction in overall symptoms 
at 8 weeks
Samadi et al, 
2013
40 University students, 
Iran (18–25 years)
Aerobic exercise; 8- weeks duration, 
three sessions per week, 60 minutes per 
session. Hand weights added to one 
session per week, intensity gradually 
increased
Usual care Premenstrual 
syndrome standard 
option complaint 
check list (unvalidated 
tool)
Statistically significant 
reduction in overall, 
psychological, and physical 




(no age range or 
recruitment pool 
given)
Two aerobic exercise intervention 
groups: high intensity and moderate 
intensity; 12- weeks duration, three 
sessions per week, 50 minutes per 
session. Specialist supervision for all 
sessions




reduction in psychological and 
physical symptoms at 12 weeks
Yang and Kim, 
2016
40 Nursing students, 
Republic of Korea
(18–25 years)
Yoga; 12 weeks per duration, one 
session per week, 60 minutes per 
session
Usual care (asked 
to refrain from 
practising yoga)




reduction in overall symptoms 
at 12 weeks
Yekke Fallah et 
al, 2013
70 University students, 
Iran (18–32 years)
Two intervention groups: aerobic, 
fast walking; 12- weeks duration, daily 
sessions, 30 minutes per session
Usual care Jack Tips Reduction in psychological and 
physical symptoms at 12 weeks 
regardless of intervention; not 
statistically significant







patients, Iran (age 
range not reported)
Aerobic exercise; 8- weeks duration, 
three sessions per week, 60 minutes per 
session
Consumed placebo 
pill (two further 
intervention groups 





reduction in overall symptoms 
at 8 weeks
Pearce E et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101032
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in SMD for psychological symptoms in the exercise group relative to comparators (SMD = -1.67; 
95% CI = −2.38 to –0.96). Significant heterogeneity was present (I2 = 89%). Seven of the 15 trials 
reported data exploring the effect of exercise interventions on physical symptoms of PMS (n = 397 
participants),27,30,31,35,38–40 and meta- analysis showed a statistically significant reduction in SMD for 
women randomised to exercise interventions compared with comparators (SMD = -1.62; 95% CI = 
Figure 2 Forest plot for primary outcome: exercise versus control for overall symptom reduction.
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-2.41 to -0.83). Heterogeneity was significant (I2 = 91%). Two of the 15 trials examined the effect of 
the exercise interventions on behavioural symptoms (n = 92 participants),28,40 and meta- analysis found 
a statistically significant reduction in SMD relative to comparators (SMD = -1.94; 95% CI = -2.45 to 
-1.44) with I2 = 0 (see Supplementary Figures S2- S4).
GRADE assessment showed the overall strength of the evidence for all four outcomes to be 
moderate (Figure 4). Evidence was downgraded from high strength owing to the large number of 
included trials at high or very high risk of bias.
Discussion
Summary
This systematic review provides some further support for clinical guidelines that recommend exercise 
as an effective treatment for PMS. The secondary analyses conducted also provide new evidence that 
exercise might be useful in alleviating specific psychological, physical, and behavioural symptoms 
associated with PMS, as well as assisting with management of the global symptom profile.
Figure 3 Risk of bias summary. CI = confidence interval. df = degrees of freedom. IV = inverse variance. SD = standard deviation.
Figure 4 Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment of overall strength of evidence.
Pearce E et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101032
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Strengths and limitations
These results should be interpreted cautiously owning to the heterogeneity seen throughout the review. 
A wide variety of exercise types were included in this review, and the interventions also differed in 
length and setting. A random- effects meta- analysis model was used to account for this heterogeneity 
and subgroup analyses were carried out where possible. The initial intention was to further explore 
any heterogeneity in intervention type; however, too few studies were identified to enable this to 
be feasible. No studies followed- up women post- intervention so any lasting effects of exercise on 
symptoms cannot be assessed at this point. Twelve of the 15 included trials were conducted in Iran, 
where although the prevalence of PMS is similar to that of the UK, the cultural meaning around 
women’s health and health care more generally may make these results less applicable for some UK 
women. Most studies recruited small samples, and many did not include a clear description of the 
interventions assessed, making classifications difficult. Only one of the 15 included trials clearly pre- 
specified their outcomes,36 and different outcome measures were used to assess symptoms across 
trials.
This review has several strengths. PRISMA guidelines were followed throughout, and the a priori 
registration of a protocol in PROSPERO utilises all current best- practice guidance for systematic 
reviews. A comprehensive search strategy, developed in line with similar reviews, was used and multiple 
electronic databases and grey literature were searched for eligible trials. No language restrictions 
were made; therefore, it is unlikely that eligible studies were missed for this reason. A native Persian 
speaker translated all Persian language studies. In only including RCTs in this review, it is hoped the 
highest quality of evidence currently available on this question has been utilised. The included trials 
represent women of a range of ages recruited from a variety of clinical and non- clinical settings. For 
the first time this review descriptively and quantitatively summarises the available evidence on the 
question of whether exercise is an effective treatment of the symptoms of PMS.
Comparison with existing literature
The results of this review are in overall agreement with an earlier systematic review by Daley, although 
that review used broader inclusion criteria, particularly in relation to study design.17 The narrative 
aspect of this updated systematic review examined 15 trials that span a wider range of exercise types 
and included more participants than the previous review (n = 72 versus n = 717), but concerns about 
trial quality remain, along with insufficient reporting detail. The meta- analysis results reported here are 
consistent with other reviews that have reported exercise to be an effective intervention for primary 
dysmenorrhoea, and for improving mental and physical health outcomes in the population.15,42,43 
Exercise is also recommended by the American College of Sports Medicine and NICE to enhance the 
initial management and advice given on other lifestyle issues known to be associated with PMS, such 
as obesity and depression.44–46
Implications for research and practice
The results of this systematic review support the recommendation that GPs and other primary 
healthcare professionals caring for women with PMS should consider exercise as part of their treatment 
plan. The research recommendations are centred on improving reporting practices, and measures to 
improve the quality of future trials. It is already strongly suggested that future research in this area 
should use either the Daily Rating of Severity of Problems18 or the Premenstrual Symptoms Screening 
Tool47 alone,: both measure and report global symptom change, as well as symptom cluster results, 
such as those reported here. By re- administering one of these questionnaires at intervals of 6 months 
or 1 year, further information relating to the persistence of the positive effects of exercise beyond the 
end of the trial period could be investigated. If larger sample sizes are used, then subgroup analysis 
by age, contraceptive use, or other demographic factors may be carried out by future systematic 
reviewers. Finally, by using the internationally recognised Consolidated Standards of Reporting Trials 
guidelines,48 then the changes suggested above will be clearly communicated to future clinicians and 
researchers, and can be acted on appropriately.
This systematic review finds that exercise may be an effective treatment for PMS. GPs and other 
primary healthcare professionals may wish to advise patients that exercise might help reduce their 
PMS symptoms, but should do so with caution until better- quality evidence becomes available.
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